No abstract available
MeSH terms
-
Child
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Grants and funding
Funding: This project was funded by the Deutsche Kinderkrebsstiftung (DKS 2021.21). YLB and GG were supported by the BMBF MyPred consortium (01GM1911A).